Olema Pharmaceuticals (OLMA) Payables (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Payables of $3.7 million for Q1 2026, up 2362.91% year-over-year from $151000.0 in Q1 2025, and down 59.81% quarter-over-quarter from $9.3 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Payables (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Payables data on file, last reported at $3.7 million in Q1 2026.
- Payables for Q1 2026 came in at $3.7 million, up 2362.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 2362.91% YoY), and the FY2025 annual result was $9.3 million, up 107.47% from the prior year.
- Payables declined to $3.7 million in Q1 2026 per OLMA's latest filing, from $9.3 million in the prior quarter.
- Over five years, Payables peaked at $9.3 million in Q4 2025 and troughed at $14000.0 in Q3 2022.
- A 5-year average of $2.6 million and a median of $2.2 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables soared 15664.29% in 2023, then tumbled 98.03% in 2025.
- A 5-year view of Payables shows it stood at $374000.0 in 2022, then jumped by 621.39% to $2.7 million in 2023, then jumped by 65.31% to $4.5 million in 2024, then soared by 107.47% to $9.3 million in 2025, then tumbled by 59.81% to $3.7 million in 2026.
- Business Quant data shows OLMA's Payables at $3.7 million in Q1 2026, $9.3 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Olema Pharmaceuticals | 1.01 Bn | 1.01 Bn | - | 3.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 9.25 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 4.35 Mn |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.21 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 681,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 268,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 306,000.00 |
| Jun 30, 2021 | 385,000.00 |